Physician profile
Steven M Melcher
NPI 1356314355
$4,010.22
in general payments reported to CMS, 2019-2025
34 companies · $705 in 2025
The $705 reported for 2025 was more than what 80% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,287 · 2020: $311 · 2021: $294 · 2022: $550 · 2023: $463 · 2024: $400 · 2025: $705.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,568.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,567.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $762.25 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $471.16 | 2019-2025 | Breztri, Farxiga, Airsupra |
| Abbvie INC. | $456.18 | 2021-2025 | |
| Lilly USA, LLC | $258.23 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Pfizer INC. | $202.35 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $169.33 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $164.78 | 2019-2023 | |
| Amarin Pharma, INC. | $161.76 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $158.12 | 2019-2025 | Jardiance |
| Glaxosmithkline, LLC. | $143.01 | 2019-2023 | Trelegy Ellipta |
| Abbott Laboratories | $135.94 | 2021-2025 | Freestyle Libre 3 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $108.77 | 2019-2024 | Xifaxan |
| Amgen INC. | $102.81 | 2019-2024 | Repatha, Otezla |
| Janssen Pharmaceuticals, INC | $99.82 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $59.65 | 2021-2023 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $53.60 | 2020-2025 | Xyosted |
| Allergan, INC. | $52.50 | 2019-2020 | |
| Exact Sciences Corporation | $47.11 | 2023-2024 | Cologuard Collection Kit |
| Supernus Pharmaceuticals, INC. | $45.20 | 2022 | |
| Mylan Specialty L.P. | $44.85 | 2019-2020 | |
| Inspire Medical Systems, INC. | $39.35 | 2025 | Inspire |
| Esperion Therapeutics, INC. | $34.47 | 2024 | Nexletol |
| Cranial Technologies, INC | $32.56 | 2022-2024 | Doc Band |
| Jazz Pharmaceuticals INC. | $31.93 | 2019 | |
| Astellas Pharma US INC | $29.07 | 2019-2023 | Myrbetriq |
| Novartis Pharmaceuticals Corporation | $24.05 | 2021 | |
| Nalpropion Pharmaceuticals LLC | $22.36 | 2019 | |
| Sumitomo Pharma America, INC. | $18.55 | 2025 | Gemtesa |
| Phathom Pharmaceuticals, INC. | $16.33 | 2025 | Voquezna |
| Shire North American Group INC | $14.48 | 2019 | |
| Circassia INC. | $14.12 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $12.30 | 2020 | |
| Upsher-Smith Laboratories LLC | $11.86 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $11.37 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Melcher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.